MLYS reports Thursday, Feb 11, 2027, after the close. After the last 4 reports the stock moved −10.4%, −1.0%, −2.6%, −3.0% the next day.
MLYS is expected to report on Thursday, Feb 11, 2027, after the close (US Eastern time).
| Report | EPS est. | EPS | Next day | Week |
|---|---|---|---|---|
| Nov 4, 2026 | -0.54 | -0.64 | −10.4% | −4.9% |
| Aug 11, 2026 | -0.53 | -2.85 | −1.0% | −2.6% |
| May 6, 2026 | -0.44 | -0.47 | −2.6% | −10.8% |
| Mar 12, 2026 | -0.52 | -0.40 | −3.0% | −13.7% |
| Nov 10, 2025 | -0.61 | -0.52 | +5.9% | −0.5% |
| Aug 12, 2025 | -0.74 | -0.66 | +0.4% | +7.1% |
| May 12, 2025 | -0.98 | -0.79 | +1.2% | +2.1% |
| Feb 12, 2025 | -1.08 | -0.98 | +10.0% | −3.5% |
Average move the next trading day over the last 8 reports: ±4.3% (4 of 8 up).
MLYS is in a downtrend, momentum soft. $14 is the level overhead; $13 the first support below.
MLYS at $13.66. Nearest resistance $14.00 (+2.5%). Nearest support $13.00 (−4.8%).
MLYS chart, levels and analysis · Latest analysis: Mineralys Therapeutics (MLYS) stock analysis, November 15, 2026: Downtrend persists, breakout unlikely · Earnings this week
MLYS is expected to report on Thursday, Feb 11, 2027, after the close.
MLYS reports after the close, US Eastern time.
After its report on Nov 4, 2026, MLYS moved −10.4% the next trading day.
Over the last 8 reports, MLYS moved 4.3% on average the next trading day, up 4 times out of 8.
Updated Nov 5, 2026 · Methodology · Research & education, not advice. Dates from company calendars via Yahoo Finance; moves from daily closes.
MarketCrew provides AI-generated market analysis and tools for informational and educational purposes only. Nothing here is investment advice or a recommendation to buy or sell any security, and it is not tailored to your circumstances. MarketCrew is not a registered investment adviser or broker-dealer. Markets involve risk, including the possible loss of principal — do your own research. © MarketCrew.